InnovAge (INNV) Projected to Announce Earnings on Tuesday

InnovAge (NASDAQ:INNV) is expected to announce its Q4 2026 results after the market closes on Tuesday, September 8th. Analysts expect InnovAge to announce earnings of $0.0747 per share and revenue of $238.3340 million for the quarter. Parties can find conference call details on the company’s upcoming Q4 2026 earning summary page for the latest details on the call scheduled for Tuesday, September 8, 2026 at 5:00 PM ET.

InnovAge Trading Down 0.2%

INNV stock opened at $10.75 on Friday. The company has a market capitalization of $1.46 billion, a price-to-earnings ratio of -119.44 and a beta of 0.40. The business has a 50 day simple moving average of $11.24 and a two-hundred day simple moving average of $9.28. InnovAge has a 1-year low of $3.69 and a 1-year high of $12.64. The company has a debt-to-equity ratio of 0.26, a current ratio of 1.03 and a quick ratio of 1.03.

Institutional Investors Weigh In On InnovAge

Several hedge funds have recently modified their holdings of INNV. T. Rowe Price Investment Management Inc. increased its holdings in InnovAge by 10.3% during the fourth quarter. T. Rowe Price Investment Management Inc. now owns 6,168,330 shares of the company’s stock valued at $32,014,000 after buying an additional 577,558 shares during the period. Marshall Wace LLP bought a new position in InnovAge in the fourth quarter worth approximately $1,512,000. O Shaughnessy Asset Management LLC lifted its holdings in InnovAge by 1,978.3% during the fourth quarter. O Shaughnessy Asset Management LLC now owns 238,881 shares of the company’s stock worth $1,240,000 after buying an additional 227,387 shares during the period. Kent Lake PR LLC lifted its holdings in InnovAge by 13.1% during the second quarter. Kent Lake PR LLC now owns 1,697,036 shares of the company’s stock worth $6,262,000 after buying an additional 197,036 shares during the period. Finally, Welch Capital Partners LLC NY boosted its position in InnovAge by 22.6% during the 2nd quarter. Welch Capital Partners LLC NY now owns 448,775 shares of the company’s stock valued at $1,656,000 after acquiring an additional 82,868 shares in the last quarter. Hedge funds and other institutional investors own 12.26% of the company’s stock.

Wall Street Analyst Weigh In

Several brokerages recently issued reports on INNV. Weiss Ratings reissued a “sell (d-)” rating on shares of InnovAge in a research note on Thursday, August 13th. Wall Street Zen lowered InnovAge from a “buy” rating to a “hold” rating in a research report on Sunday, May 17th. Finally, KeyCorp upgraded InnovAge from a “sector weight” rating to an “overweight” rating and set a $13.00 target price for the company in a report on Friday, August 21st. One equities research analyst has rated the stock with a Buy rating, one has given a Hold rating and two have issued a Sell rating to the company. According to data from MarketBeat.com, InnovAge currently has a consensus rating of “Reduce” and a consensus price target of $10.00.

About InnovAge

InnovAge Holdings, Inc (NASDAQ:INNV) is a healthcare services company that specializes in caring for seniors through the Program of All-Inclusive Care for the Elderly (PACE). Designed for individuals who are eligible for both Medicare and Medicaid, the PACE model integrates medical care, social services and long-term care—delivered primarily in participants’ homes and community-based centers. InnovAge’s approach centers on interdisciplinary care teams that coordinate everything from primary and specialty medical services to nutritional counseling and recreational activities.

The company’s core offerings include comprehensive in-home assessments, physician and nursing services, physical and occupational therapy, prescription medication management, and transportation to medical appointments.